Vera Therapeutics, Inc.
VERA
$21.71
-$0.32-1.45%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -86.06% | -58.50% | -30.75% | -0.47% | 7.58% |
| Total Depreciation and Amortization | 208.36% | 7,447.62% | 364.48% | 305.42% | 139.53% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 75.37% | 37.61% | 5.05% | -40.50% | -42.55% |
| Change in Net Operating Assets | 111.89% | 145.69% | -72.58% | -202.45% | -908.25% |
| Cash from Operations | -55.69% | -46.10% | -36.78% | -27.60% | -17.44% |
| Capital Expenditure | -1,739.68% | -1,442.86% | -- | -300.00% | -43.18% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 30.13% | -977.16% | -314.59% | -227.68% | -1,339.44% |
| Cash from Investing | 29.72% | -977.91% | -315.47% | -227.72% | -1,336.42% |
| Total Debt Issued | -- | -- | 24.85% | 24.85% | 24.85% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 19.58% | 456.55% | 155.74% | 153.87% | 152.14% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -19.50% | -440.61% | -148.59% | -146.26% | -146.26% |
| Cash from Financing | 9.79% | 354.30% | 136.09% | 134.64% | 133.01% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 79.56% | 2,334.68% | 94.44% | 47.69% | -364.98% |